- Analysis
- Barani Krishnan
- 5
Beijing Tongrentang Co., Ltd engages in the scientific research, production, distribution, and sale of Chinese medicines in China. The company provides product dosage forms, such as pills, powders, wine preparations, capsules, and oral liquids in the areas of cardiovascular, gynecology, heat clearing class, respiratory system, nourishing and calming, digestive system, pediatrics, wind-dispelling and dampness-removing, orthopedics, five senses, dermatology, psychological, and food and wine. The company was founded in 1997 and is headquartered in Beijing, China. Beijing Tongrentang Co., Ltd operates as a subsidiary of China Beijing Tongrentang (Group) Co., Ltd.
Metrics to compare | 600085 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600085PeersSector | |
---|---|---|---|---|
P/E Ratio | 31.3x | 19.5x | −0.6x | |
PEG Ratio | −3.02 | 0.09 | 0.00 | |
Price/Book | 3.9x | 2.0x | 2.6x | |
Price / LTM Sales | 2.8x | 2.2x | 3.1x | |
Upside (Analyst Target) | 34.8% | 28.0% | 54.8% | |
Fair Value Upside | Unlock | 14.0% | 7.9% | Unlock |